Purchase Order 75N95025P00264
Award Date
4/28/25
Potential Completion Date
5/1/26
Potential Value
$22K
Federal Agency
National Institute on Drug Abuse
Awardee
Becton, Dickinson And Company
Ultimate Awardee
Becton, Dickinson & Co
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Becton, Dickinson and Company (BD), a global medical technology company, for the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH). The contract is a delivery order under BD's General Services Administration (GSA) Schedule 66 contract for Scientific Equipment and Services. The contract has a ceiling value of $50,978.04 and will run through December 31, 2019. The contract is for firm fixed-price delivery of products...
Becton, Dickinson and Company (BD Biosciences division) has been awarded a firm fixed price purchase order contract valued at $15,000 by the National Institutes of Health's National Institute on Drug Abuse. The contract is for the delivery of PM KIT FACSMELODY, LABOR, AND PARTS BD BIOSCIENCES - CLONTECH:1109645 to support biomedical research activities at a place of performance in Baltimore, Maryland. No set-aside designation was used for this procurement. The contract has a period of...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $241,407.00 firm fixed price purchase order to Becton, Dickinson And Company (BD), a global medical technology company, for the acquisition of a fluorescence-activated cell sorting (FACS) Melody system. This FACS system will be primarily used by the Behavioral Neuroscience Research Branch to isolate fluorescently labeled cells and nuclei from the brain to assess molecular and...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for a service agreement to provide a FACSMelody cell sorter. The contract has a ceiling value of $16,092 and a completion date of December 19, 2022. This award is not associated with a set-aside program. BD is a global medical technology company that provides specialized instruments,...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $33,675.60. The contract is for BD Biosciences, a division of BD, to provide biomedical instruments, reagents, and services that support flow cytometry, cell imaging, and genomics technologies. BD has extensive experience providing specialized equipment and consumables to support...
This is a $600,264.33 firm-fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Becton, Dickinson and Company (BD), a manufacturer of medical devices, instruments, reagents, and related products. The contract is for the delivery of a BD FACSymphony A-5 30-color flow cytometer, a specialized laboratory instrument used for advanced cellular analysis. BD, through its IDS division operating...
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $125,877.00. The contract is for an annual service agreement to maintain BD's FACS (fluorescence-activated cell sorting) flow machines and accessories used to support biomedical research and clinical applications at NIAID. The contract does not have a set-aside designation. BD is...
This is a $15,922.00 firm fixed price purchase order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to Becton, Dickinson and Company (BD) for in-vitro diagnostic substances, specifically high parameter flow cytometer antibodies. The contract has an ultimate completion date of October 22, 2024 and was awarded on September 23, 2024. There was no set-aside designation used for this award. BD is a global medical technology company that provides a wide range...
This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
This is a delivery order contract awarded to Becton, Dickinson and Company (BD), a global medical technology company, by the National Institute on Drug Abuse (NIDA), a civilian agency. The contract, with a ceiling value of $45,005.88, is a firm fixed-price Delivery Order under the Scientific Equipment and Services (FSS-66) General Services Administration (GSA) Multiple Award Schedule contract. The contract has no set-aside designation and is for the delivery of specialized medical equipment...